These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22582358)

  • 1. MR imaging of hypervascular lesions in the cirrhotic liver: a diagnostic dilemma.
    Parente DB; Perez RM; Eiras-Araujo A; Oliveira Neto JA; Marchiori E; Constantino CP; Amorim VB; Rodrigues RS
    Radiographics; 2012; 32(3):767-87. PubMed ID: 22582358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features.
    Hanna RF; Aguirre DA; Kased N; Emery SC; Peterson MR; Sirlin CB
    Radiographics; 2008; 28(3):747-69. PubMed ID: 18480482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.
    Earls JP; Theise ND; Weinreb JC; DeCorato DR; Krinsky GA; Rofsky NM; Mizrachi H; Teperman LW
    Radiology; 1996 Oct; 201(1):207-14. PubMed ID: 8816545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis.
    Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
    Dig Liver Dis; 2015 Sep; 47(9):775-82. PubMed ID: 26043653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI and pathology aspects of hypervascular nodules in cirrhotic liver: from dysplasia to hepatocarcinoma.
    Gheonea IA; Streba CT; Cristea CG; Stepan AE; Ciurea ME; Sas T; Bondari S
    Rom J Morphol Embryol; 2015; 56(3):925-35. PubMed ID: 26662124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
    Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma.
    Cereser L; Furlan A; Bagatto D; Girometti R; Como G; Avellini C; Orsaria M; Zuiani C; Bazzocchi M
    J Comput Assist Tomogr; 2010; 34(5):706-11. PubMed ID: 20861773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration.
    Golfieri R; Grazioli L; Orlando E; Dormi A; Lucidi V; Corcioni B; Dettori E; Romanini L; Renzulli M
    J Magn Reson Imaging; 2012 Sep; 36(3):648-57. PubMed ID: 22592930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural course of small nodular lesions with intranodular preserved portal supply in cirrhotic liver.
    Fukunaga T; Kudo M; Tochio H; Okabe Y; Orino A
    Oncology; 2007; 72 Suppl 1():24-9. PubMed ID: 18087179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma: development and early detection.
    Robinson P
    Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S128-31. PubMed ID: 18852086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers.
    Bartolozzi C; Battaglia V; Bargellini I; Bozzi E; Campani D; Pollina LE; Filipponi F
    Abdom Imaging; 2013 Apr; 38(2):290-6. PubMed ID: 23053453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.
    Kim JI; Lee JM; Choi JY; Kim YK; Kim SH; Lee JY; Han JK; Choi BI
    Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.
    Hussain SM; Zondervan PE; IJzermans JN; Schalm SW; de Man RA; Krestin GP
    Radiographics; 2002; 22(5):1023-36; discussion 1037-9. PubMed ID: 12235331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion-weighted MRI in evaluating the intranodular hemodynamic characteristics of dysplastic nodules and hepatocellular carcinomas in an experimental rat model.
    Xu H; Xie JX; Li X; Yang ZH; Zheng ZZ; Wang B; Wang Z
    J Magn Reson Imaging; 2008 Jan; 27(1):102-9. PubMed ID: 18022847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.